Cargando…
Upper-body extracorporeal membrane oxygenation as a strategy in decompensated pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a disease with significant morbidity and mortality, particularly during an acute decompensation. We describe a single-center experience of three patients with severe Group 1 PAH, refractory to targeted medical therapy, in which an extubated, nonsedated, extra...
Autores principales: | Abrams, Darryl C., Brodie, Daniel, Rosenzweig, Erika B., Burkart, Kristin M., Agerstrand, Cara L., Bacchetta, Matthew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757840/ https://www.ncbi.nlm.nih.gov/pubmed/24015346 http://dx.doi.org/10.4103/2045-8932.113178 |
Ejemplares similares
-
Early mobilization of patients receiving extracorporeal membrane oxygenation: a retrospective cohort study
por: Abrams, Darryl, et al.
Publicado: (2014) -
The Evolution of the Use of Extracorporeal Membrane Oxygenation in Respiratory Failure
por: Feldhaus, Danielle, et al.
Publicado: (2021) -
The Use of Extracorporeal Membrane Oxygenation for COVID-19: Lessons Learned
por: Parekh, Madhavi, et al.
Publicado: (2023) -
How I manage differential gas exchange in peripheral venoarterial extracorporeal membrane oxygenation
por: Asija, Richa, et al.
Publicado: (2023) -
Medicating patients during extracorporeal membrane oxygenation: the evidence is building
por: Dzierba, Amy L., et al.
Publicado: (2017)